BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9859051)

  • 21. What does apoptosis have to do with clinical features in myelodysplastic syndrome?
    Ramos F; Fuertes-Núñez M; Suárez-Vilela D; Fernández-López A
    Haematologica; 2002 Apr; 87(4):381-91. PubMed ID: 11940482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
    Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M
    J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelodysplastic syndromes during pregnancy.
    Pagliuca A; Mufti GJ; Fenaux P; de Silva C; Samaratunga I
    Eur J Haematol; 1991 Oct; 47(4):310-2. PubMed ID: 1954992
    [No Abstract]   [Full Text] [Related]  

  • 25. Outcome of patients with myelodysplastic syndromes: experience from a single institution in South Australia.
    Hui CH; Horvath N; Lewis I; To LB; Szabo F
    Intern Med J; 2008 Nov; 38(11):824-8. PubMed ID: 18284457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Finally progress in the understanding of myelodysplastic syndromes?
    Ganser A
    Wien Klin Wochenschr; 1999 Oct; 111(19):781-3. PubMed ID: 10568009
    [No Abstract]   [Full Text] [Related]  

  • 27. [Myelodysplastic syndromes. Results from a prolonged follow-up].
    Rådlund A; Hansen S; Carlsson M; Stoméus S; Andreeva P; Jarlsfelt I; Thiede T; Engquist L
    Lakartidningen; 1993 Jun; 90(24):2299-301. PubMed ID: 8316003
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelodysplastic syndrome. When blood cell production goes wrong.
    Mayo Clin Health Lett; 2001 Mar; 19(3):4-5. PubMed ID: 11242842
    [No Abstract]   [Full Text] [Related]  

  • 30. [Myelodysplastic syndromes].
    Obradov S; Dugumović Z; Nikolić-Bartl J
    Med Arh; 1988; 42(4):167-76. PubMed ID: 3270759
    [No Abstract]   [Full Text] [Related]  

  • 31. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A 57-year-old patient with peripheral pancytopenia].
    Fink M; Prenninger S; Sauer H
    Internist (Berl); 1989 Mar; 30(3):210-3. PubMed ID: 2654063
    [No Abstract]   [Full Text] [Related]  

  • 33. Is survival enough for myelodysplastic syndromes?
    Santini V
    Leuk Res; 2009 Aug; 33(8):1017-8. PubMed ID: 19268362
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
    Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
    Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myelodysplastic syndromes].
    Turtureana-Hanganu E
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(1):57-60. PubMed ID: 2814030
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of eicosapentaenoic acid in patients with refractory myelodysplastic syndrome.
    Okamoto T; Okada M; Wakae T; Takatsuka H; Kakishita E
    Am J Hematol; 2002 Dec; 71(4):350-1. PubMed ID: 12447972
    [No Abstract]   [Full Text] [Related]  

  • 37. The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution.
    Balduini CL; Guarnone R; Pecci A; Centenara E; Invernizzi R; Ascari E
    Haematologica; 1999 Jan; 84(1):12-6. PubMed ID: 10091387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gene diagnosis and successful reversion in a patient with preleukemia].
    Feng BZ; Lei JL; Yang XY
    Zhonghua Nei Ke Za Zhi; 1992 Sep; 31(9):539-42, 586. PubMed ID: 1303846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematology problem.
    Snyder JR; Newland JR; Graves BK
    Am J Med Technol; 1981 Dec; 47(12):977-9. PubMed ID: 7332021
    [No Abstract]   [Full Text] [Related]  

  • 40. [Myelodysplastic syndromes as preleukemic states].
    Sánchez Fayos J; Pérez Rus G; Outeiriño J; Escudero A; Bosch JM; Calabuig T; Vacas J
    Sangre (Barc); 1987; 32(6):715-30. PubMed ID: 3326193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.